Technology and Media - Integrating Consumer Digital into the Marketing Mix Problem

Axtria Principals David Wood, PhD and Randy Risser present analytical techniques developed in Axtria's R&D labs.

Abstract: Pharmaceutical marketers have struggled with the challenge of optimizing the overall marketing mix for some time now, and reasonable progress has been made. However, this fails to hold with consumer marketing, particularly consumer digital marketing. A variety of channels exist (banner ads, paid search, branded websites with or without consumer registration, etc.). Some of these currently benefit from predictive. But most of these are still poorly measured (even for basic ROI) and are generally not yet fully integrated into the overall marketing process. The interaction effects with marketing to Health Care Professionals are not yet well understood, and an appropriate budgeting framework is lacking. Based on our experience in Pharma and other industries, this talk will explore these issues and approaches to solving them. Axtria will present examples that illustrate approaches for measuring ROI of digital marketing programs in Pharma (addressing the challenge that most consumer digital marketing is difficult to link to actual Rx volume) Axtria will present a framework for modeling consumer promotional channels and their interaction among each other, and with professional promotion. This allows for optimization of overall budgeting (accounting for interaction effects) and lays the groundwork for a more detailed micro-targeting on both sides. Click here for more information.

Tags: Solutions, Blog, Online Advertising, Pharmaceuticals, Digital Marketing, Digital Analytics, Announcements

Axtria Connect

Axtria combines industry knowledge, analytics and technology to help clients make better data-driven decisions. Its data analytics and cloud-based platforms support sales, marketing, and risk management decisions. It serves clients with a high-touch on-site and onshore presence, leveraged by a global delivery platform that reduces the total cost of ownership with efficient execution, innovation, and virtualization. Axtria works with more than 30 clients, including five of the Fortune 50, and eight of the top 10 global life sciences companies.